title: New insights into cystinuria: 40 new mutations, genotype-phenotype correlation, and digenic inheritance causing partial phenotype.
abstract: OBJECTIVE
  To clarify the genotype-phenotype correlation and elucidate the role of digenic inheritance in cystinuria.
  
  
  METHODS
  164 probands from the International Cystinuria Consortium were screened for mutations in SLC3A1 (type A) and SLC7A9 (type B) and classified on the basis of urine excretion of cystine and dibasic amino acids by obligate heterozygotes into 37 type I (silent heterozygotes), 46 type non-I (hyperexcretor heterozygotes), 14 mixed, and 67 untyped probands.
  
  
  RESULTS
  Mutations were identified in 97% of the probands, representing 282 alleles (86.8%). Forty new mutations were identified: 24 in SLC3A1 and 16 in SLC7A9. Type A heterozygotes showed phenotype I, but mutation DupE5-E9 showed phenotype non-I in some heterozygotes. Type B heterozygotes showed phenotype non-I, with the exception of 10 type B mutations which showed phenotype I in some heterozygotes. Thus most type I probands carried type A mutations and all type non-I probands carried type B mutations. Types B and A mutations contributed to mixed type, BB being the most representative genotype. Two mixed cystinuria families transmitted mutations in both genes: double compound heterozygotes (type AB) had greater aminoaciduria than single heterozygotes in their family.
  
  
  CONCLUSIONS
  Digenic inheritance is an exception (two of 164 families), with a limited contribution to the aminoaciduria values (partial phenotype) in cystinuria. Further mutational analysis could focus on one of the two genes (SLC3A1 preferentially for type I and SLC7A9 for type non-I probands), while for mixed probands analysis of both genes might be required, with priority given to SLC7A9.
authors.affiliation: Centre of Medical and Molecular Genetics (IRO), Hospital Duran i Reynals, Barcelona, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Font-Llitjós
authors.forename: M
authors.initials: M
authors.lastname: Jiménez-Vidal
authors.forename: L
authors.initials: L
authors.lastname: Bisceglia
authors.forename: M
authors.initials: M
authors.lastname: Di Perna
authors.forename: L
authors.initials: L
authors.lastname: de Sanctis
authors.forename: F
authors.initials: F
authors.lastname: Rousaud
authors.forename: L
authors.initials: L
authors.lastname: Zelante
authors.forename: M
authors.initials: M
authors.lastname: Palacín
authors.forename: V
authors.initials: V
authors.lastname: Nunes
mesh_terms: D026923:Amino Acid Transport Systems, Basic / Q000235:genetics; D026921:Amino Acid Transport Systems, Neutral / Q000235:genetics; D003555:Cystinuria / Q000235:genetics*; D004252:DNA Mutational Analysis; D006580:Genetic Carrier Screening; D005838:Genotype; D006801:Humans; D009154:Mutation; D010641:Phenotype
chemical_list: D026923:Amino Acid Transport Systems, Basic; D026921:Amino Acid Transport Systems, Neutral; C489857:SLC3A1 protein, human; C499489:SLC7A9 protein, human